Recent Finacing
Recent Raise
Alebund Pharmaceuticals, a Shanghai-based clinical-stage biopharma, develops therapies for kidney diseases (CKD, IgA nephropathy, diabetic kidney disease, ADPKD, dialysis complications); hyperphosphatemia candidate in Phase II.
